Back to results
US 8,409,812 B2Granted
Annexin A3 for cancer diagnosis
AssigneeProteosys AG
InventorsMichael Cahill, André Schrattenholz
Life of this patent
Estimating the term…
Abstract
A method treats urogenital and/or intestinal tract cancer and includes administering a therapeutically effective amount of at least one annexion protein, annexin of A3, to a mammal.
Claims20
A method of diagnosing prostate and/or colon cancer and/or discrimination between prostate and/or colon cancerous and non-cancerous tissue, comprising:
- determining abundance of extracellular human annexin A3 protein,
- in urine samples or fractions thereat wherein the urine samples or fractions thereof are subjected to a separation process to yield cell pellets and supernatants prior to determining the abundance of human annexin A3 protein, whereby the diagnosis of prostate and/or colon cancer and/or discrimination between prostate and/or colon cancerous and non-cancerous tissue is made by using the supernatants to determine the extracellular abundance of human annexin A3 protein.
Dependencies are inferred from the claim text.